VCM
CORZ icon

Versant Capital Management’s Core Scientific CORZ Stock Holding History

Versant Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8K Sell
538
-3,138
-85% -$73.9K ﹤0.01% 2119
2026
Q1 		$55K Buy
+3,676
New +$62.7K 0.01% 1178
2025
Q2 		– Sell
-1,000
Closed -$7.24K – 2649
2025
Q1 		$7.24K Buy
+1,000
New +$11.4K ﹤0.01% 1879

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Versant Capital Management's CORZ Position: Q2 2026 in Review

Versant Capital Management reduced its Core Scientific (CORZ) stake by 85% in Q2 2026, selling an estimated $73.9K and leaving 538 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2119.

Versant Capital Management first reported a position in CORZ in Q1 2025 and has held it in 3 quarters since. The position peaked at $55K in Q1 2026. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Versant Capital Management held 538 shares of Core Scientific worth $13.8K as of Q2 2026.
  • Versant Capital Management sold 3,138 Core Scientific shares in Q2 2026, an estimated $73.9K.
  • Core Scientific made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2119 holding.
  • Versant Capital Management first reported a position in Core Scientific in Q1 2025 and has held it in 3 quarters since.
  • Versant Capital Management's Core Scientific position peaked at $55K in Q1 2026.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.